Literature DB >> 12417438

Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells.

Frauke Forstreuter1, Ralph Lucius, Rolf Mentlein.   

Abstract

Vascular endothelial growth factor (VEGF) is an angiogenic peptide that is produced in the brain after ischemia, injury or in malignant gliomas. Since these pathological conditions are associated with the infiltration of microglial cells, we investigated the expression of VEGF receptors (VEGFR) and possible effects of VEGF on cultivated microglial cells. As shown by reverse transcription-polymerase chain reaction and immunocytochemistry, rat microglial cells as well as the murine cell line BV-2 express the VEGFR-1, but not VEGFR-2. Murine VEGF induced 3H-thymidine incorporation into DNA of murine and rat microglial cells as well as chemotaxis in Boyden chamber assays. However, VEGF did not alter the phosphorylation of mitogen-activated protein kinases and only slightly that of the kinase Akt. These results show that microglial cells are targets for VEGF which induces migration and proliferation of these immunocompetent cells in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417438     DOI: 10.1016/s0165-5728(02)00315-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  53 in total

Review 1.  Microglial interactions with the neurovascular system in physiology and pathology.

Authors:  Xiaoliang Zhao; Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Dev Neurobiol       Date:  2018-02-01       Impact factor: 3.964

Review 2.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

Review 3.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

4.  An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.

Authors:  Yunyun Liu; Xiaoyu Li; Yuanpei Zhang; Hongxuan Wang; Xiongming Rong; Jialing Peng; Lei He; Ying Peng
Journal:  Oncogene       Date:  2019-08-19       Impact factor: 9.867

5.  Expression of cyclooxygenases and trophic and growth factors in epiretinal membranes at late stages of proliferative vitreoretinopathy.

Authors:  Marina Tikhonovich; Pavel Lyskin; Elena Ioyleva; Svetlana Gavrilova
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-02       Impact factor: 3.117

6.  Microglial chemotactic signaling factors in Alzheimer's disease.

Authors:  James G McLarnon
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

7.  Functional significance of vascular endothelial growth factor receptor expression on human glioma cells.

Authors:  Rolf Mentlein; Frauke Forstreuter; Hubertus M Mehdorn; Janka Held-Feindt
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 8.  Neuroprotection in the newborn infant.

Authors:  Fernando F Gonzalez; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

9.  Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.

Authors:  Koen Poesen; Diether Lambrechts; Philip Van Damme; Joke Dhondt; Florian Bender; Nicolas Frank; Elke Bogaert; Bart Claes; Line Heylen; An Verheyen; Katrien Raes; Marc Tjwa; Ulf Eriksson; Masabumi Shibuya; Rony Nuydens; Ludo Van Den Bosch; Theo Meert; Rudi D'Hooge; Michael Sendtner; Wim Robberecht; Peter Carmeliet
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

Review 10.  Angiogenesis factors in gliomas: a new key to tumour therapy?

Authors:  Rolf Mentlein; Janka Held-Feindt
Journal:  Naturwissenschaften       Date:  2003-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.